Eur Rev Med Pharmacol Sci 2020; 24 (9): 5189-5191
DOI: 10.26355/eurrev_202005_21218

Editorial – COVID-19 and the microbiota: new kids on the block

G. Gasbarrini, T. Dionisi, F. Franceschi, A. Gasbarrini

Istituto di Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy. tommasodionisi@libero.it

Free PDF Download

To cite this article

G. Gasbarrini, T. Dionisi, F. Franceschi, A. Gasbarrini
Editorial – COVID-19 and the microbiota: new kids on the block

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 9
Pages: 5189-5191
DOI: 10.26355/eurrev_202005_21218

Keywords Related articles:

  1. Editorial – COVID-19, more than a viral pneumonia
  2. Editorial – High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients
  3. Editorial – COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past?
  4. Editorial – Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents
  5. Biliary tract microbiota: a new kid on the block of liver diseases?